EP0797592A4 - HUMAN STANNIOCALCIN ALPHA - Google Patents

HUMAN STANNIOCALCIN ALPHA

Info

Publication number
EP0797592A4
EP0797592A4 EP95904073A EP95904073A EP0797592A4 EP 0797592 A4 EP0797592 A4 EP 0797592A4 EP 95904073 A EP95904073 A EP 95904073A EP 95904073 A EP95904073 A EP 95904073A EP 0797592 A4 EP0797592 A4 EP 0797592A4
Authority
EP
European Patent Office
Prior art keywords
alpha
human stanniocalcin
stanniocalcin
human
stanniocalcin alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95904073A
Other languages
German (de)
French (fr)
Other versions
EP0797592A1 (en
Inventor
Henrik Olsen
Robert D Fleischmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of EP0797592A1 publication Critical patent/EP0797592A1/en
Publication of EP0797592A4 publication Critical patent/EP0797592A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00Uses of viruses
    • C12N2799/02Uses of viruses as vector
    • C12N2799/021Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • General Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Nutrition Science (AREA)
  • Microbiology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EP95904073A 1994-11-10 1994-11-10 HUMAN STANNIOCALCIN ALPHA Withdrawn EP0797592A4 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1994/013206 WO1996015147A1 (en) 1994-11-10 1994-11-10 Human stanniocalcin-alpha

Publications (2)

Publication Number Publication Date
EP0797592A1 EP0797592A1 (en) 1997-10-01
EP0797592A4 true EP0797592A4 (en) 1999-10-20

Family

ID=22243284

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95904073A Withdrawn EP0797592A4 (en) 1994-11-10 1994-11-10 HUMAN STANNIOCALCIN ALPHA

Country Status (6)

Country Link
EP (1) EP0797592A4 (en)
JP (1) JPH10509036A (en)
KR (1) KR100432260B1 (en)
AU (1) AU687962B2 (en)
NZ (1) NZ277605A (en)
WO (1) WO1996015147A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6008322A (en) * 1996-04-02 1999-12-28 Zymogenetics, Inc. Stanniocalcin-2
US6538119B2 (en) * 1997-11-18 2003-03-25 Abbott Laboratories Reagents and methods useful for detecting diseases of the breast
ES2288016T3 (en) * 1998-04-10 2007-12-16 Daiichi Sankyo Company, Limited HUMAN STAYCALCINE AND USES OF THE SAME TO INHIBIT ADIPOGENESIS.
CA2389964A1 (en) 1999-11-04 2001-05-10 Diadexus, Inc. A novel method of diagnosing, monitoring, staging, imaging and treating cancer

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995024411A1 (en) * 1994-03-08 1995-09-14 Human Genome Sciences, Inc. Corpuscles of stannius protein, stanniocalcin

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988003949A1 (en) * 1986-11-21 1988-06-02 Howard Florey Institute Of Experimental Physiology The cs protein of the corpuscles of stannius

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995024411A1 (en) * 1994-03-08 1995-09-14 Human Genome Sciences, Inc. Corpuscles of stannius protein, stanniocalcin

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BUTKUS A ET AL: "PURIFICATION AND CLONING OF A CORPUSCLES OF STANNIUS PROTEIN FROM ANGUILLA AUSTRALIS", MOLECULAR AND CELLULAR ENDOCRINOLOGY, vol. 54, no. 2/03, 1 December 1987 (1987-12-01), pages 123 - 133, XP000605664, ISSN: 0303-7207 *
See also references of WO9615147A1 *
WAGNER G F ET AL: "MOLECULAR CLONING AND CDNA SEQUENCE ANALYSIS OF COHO SALMON STANNIOCALCIN", MOLECULAR AND CELLULAR ENDOCRINOLOGY, vol. 90, no. 1, 1 December 1992 (1992-12-01), pages 7 - 15, XP000605660, ISSN: 0303-7207 *

Also Published As

Publication number Publication date
AU1289695A (en) 1996-06-06
NZ277605A (en) 1999-03-29
KR970707155A (en) 1997-12-01
KR100432260B1 (en) 2004-09-16
JPH10509036A (en) 1998-09-08
AU687962B2 (en) 1998-03-05
WO1996015147A1 (en) 1996-05-23
EP0797592A1 (en) 1997-10-01

Similar Documents

Publication Publication Date Title
KR970701725A (en) Human osteoclast-derived cathepsin
DE69735996D1 (en) HUMAN BIKININE
KR970702968A (en) Crutch arrangement
FI101767B1 (en) Stretcher
DE69501291D1 (en) Loungers
DE59506122D1 (en) SKIN DISTRACTOR
FR2747557B3 (en) STETHOSCOPE
DE69307754D1 (en) tissue
EP0716098A3 (en) Pad
DE4394018T1 (en) Sphygmomanometer
DE69119306D1 (en) Sphygmomanometer
DE69409046D1 (en) endoscope
DE69606248D1 (en) Sphygmomanometer
EP0797592A4 (en) HUMAN STANNIOCALCIN ALPHA
ITMI950222A0 (en) TISSUE
KR950027629U (en) Hat leg
KR960030447U (en) Wrist sphygmomanometer
EP0787013A4 (en) HYPOXANTHINE- (GUANINE) PHOSPHORIBOSYLTRANSFERASE-2 HUMAN
DE69431892D1 (en) multiplexer
DE59107795D1 (en) Sphygmomanometer
MD940178A (en) Crutch
DE69434900D1 (en) HUMAN CHEMOKIN POLYPEPTIDE
DE69610977D1 (en) Sphygmomanometer
EP0804226A4 (en) HUMAN CHOLINE-ACETYLASE
KR950016714U (en) Patient bed

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19970610

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 6C 12N 15/16 A, 6C 12N 5/10 B, 6C 07K 14/575 B, 6C 07K 14/585 B, 6C 07K 16/26 B, 6A 61K 38/22 B, 6G 01N 33/50 B, 6C 12Q 1/68 B

A4 Supplementary search report drawn up and despatched

Effective date: 19990906

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20020125

RIN1 Information on inventor provided before grant (corrected)

Inventor name: FLEISCHMANN, ROBERT D.

Inventor name: OLSEN, HENRIK

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20060531